Carlyle Secured Lending, Inc. (CGBD)
| Market Cap | $705.95M-11.7% |
| Revenue (ttm) | $256.28M |
| Net Income | $36.88M |
| EPS | $0.51 |
| Shares Out | 68.01M |
| PE Ratio | 20.35 |
| Forward PE | 6.97 |
| Dividend | $1.40(13.25%) |
| Ex-Dividend Date | Dec 31, 2026 |
| Volume | 490,302 |
| Open | $10.52 |
| Previous Close | $10.57 |
| Day's Range | $10.29 - $10.67 |
| 52-Week Range | $9.95 - $13.28 |
| Beta | 0.71 |
| Analysts | Hold |
| Price Target | $12.21(+17.67%) |
| Earnings Date | Nov 5, 2026 |
About CGBD
Carlyle Secured Lending, Inc. is business development company specializing in first lien debt, senior secured loans, second lien senior secured loan unsecured debt, mezzanine debt and investments in equities. It specializes in directly investing. It specializes in middle market. It targets healthcare and pharmaceutical, aerospace and defense, high tech industries, business services, software, beverage food and tobacco, hotel gamming and leisure, banking finance insurance and in real estate sector. The fund seeks to invest across United States of America, Luxembourg, Cayman Islands, Cyprus, and United Kingdom. It invests in companies with EBITDA between $25 million and $100 million.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating CGBD in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 31, 2026Ex-dividend date
$CGBD stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CGBD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CGBD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CGBD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CGBD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CGBD from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from CGBD’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings miss on both revenue and earnings, though dividend maintained at $0.35/share; mixed fundamental performance.
